Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.48 |
| ▸ | GPR119 | Q8TDV5 | 7/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | RBP4 | P02753 | 1/20 | 0.43 |
| ▸ | YAP1 | P46937 | 1/20 | 0.42 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.41 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.41 |
| ▸ | FEN1 | P39748 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28616820 | 0.90 | RBP4 (0.46) | RBP4 | |
| SCHEMBL2811017 | 0.85 | SLC2A1 (0.57) | SLC2A1GPR119HDAC1CHEK2KDM4E | |
| SCHEMBL23826968 | 0.84 | GPR119 (0.52) | SLC2A1EPHX2GPR119HDAC1CHEK2 | |
| SCHEMBL2999873 | 0.83 | GPR119 (0.54) | SLC2A1GPR119HDAC1CHEK2KDM4E | |
| SCHEMBL241130 | 0.79 | GPR119 (0.59) | SLC2A1GPR119HDAC1CHEK2KDM4E | |
| SCHEMBL26668458 | 0.77 | SLC2A1 (0.59) | SLC2A1GPR119CHEK2KDM4EPKM | |
| SCHEMBL30318922 | 0.76 | GPR119 (0.54) | SLC2A1GPR119CHEK2KDM4EPKM | |
| SCHEMBL20231480 | 0.76 | GPR119 (0.54) | SLC2A1GPR119HDAC1CHEK2KDM4E | |
| SCHEMBL18818429 | 0.76 | GPR119 (0.61) | SLC2A1GPR119HDAC1CHEK2ALOX5AP | |
| SCHEMBL7472533 | 0.76 | PARP15 (0.52) | SLC2A1EPHX2GPR119HDAC1CHEK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113302184-A | 1,3, 4-oxadiazolinone compounds and drugs | 日本新药株式会社 | 2021-08-24 | — | — | CN | disclosed |